← Leaderboards
Bryan E. Welm
University Of Utah
$3,719,219
Attributed
$6,669,936
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2010–22$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$14,248,544 · 5
By mechanism
U54$8,534,572 · 3
U01$4,226,076 · 1
R01$1,487,896 · 1
Top collaborators
- Michael T Lewis12 shared
- Alana L Welm12 shared
- Gabor T Marth5 shared
- Katherine Elena Varley5 shared
Most similar at University Of Utah
Same institution · by research overlap
- Ken R Smith$12,200,387
- Nicola J Camp$10,676,027
- Lewis C Murtaugh$5,738,542
- Lisa A. Cannon Albright$14,179,490
- Geraldine P Mineau$6,862,223
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorCellsMalignant Breast NeoplasmResponseMolecularResearch PersonnelBaseStructureMammary NeoplasmsSiteGrantFutureBreast Cancer TherapyPilot ProjectsFundingCollaborationsPharmaceutical PreparationsBreast Cancer PatientOrganoidsMetastatic Breast CancerGenomicsFda ApprovedProgramsCancer Etiology
Grant awards (29)
Longitudinal models of breast cancer for studying mechanisms of therapy response and resistance$806,283
U01 · FY2022 · CA · contact PI
PDX Trial Center for Breast Cancer Therapy$520,759
U54 · FY2022 · CA
Core-001$200,000
U54 · FY2022 · CA
Tolinapant efficacy in a subset of triple negative breast cancers$200,000
U54 · FY2022 · CA
PDX Trial Center for Breast Cancer Therapy$1,240,619
U54 · FY2021 · CA
Longitudinal models of breast cancer for studying mechanisms of therapy response and resistance$812,870
U01 · FY2021 · CA · contact PI
Pilot Project and Trans-Network Activities Core$166,982
U54 · FY2021 · CA · contact PI
Multi-omic, Exposure-informed, Genealogical Approach (mErGE)$119,886
U54 · FY2021 · CA
PDX Trial Center for Breast Cancer Therapy$1,240,654
U54 · FY2020 · CA
Longitudinal models of breast cancer for studying mechanisms of therapy response and resistance$986,128
U01 · FY2020 · CA · contact PI
Pilot Project and Trans-Network Activities Core$166,986
U54 · FY2020 · CA · contact PI
PDX Trial Center for Breast Cancer Therapy$119,960
U54 · FY2020 · CA
PDX Trial Center for Breast Cancer Therapy$1,240,654
U54 · FY2019 · CA
Longitudinal models of breast cancer for studying mechanisms of therapy response and resistance$798,057
U01 · FY2019 · CA · contact PI
Pilot Project and Trans-Network Activities Core$171,923
U54 · FY2019 · CA · contact PI
PDX Trial Center for Breast Cancer Therapy$62,293
U54 · FY2019 · CA
Pilot Project and Trans-Network Activities Core$10,383
U54 · FY2019 · CA · contact PI
Longitudinal models of breast cancer for studying mechanisms of therapy response and resistance$822,738
U01 · FY2018 · CA · contact PI
PDX Trial Center for Breast Cancer Therapy$176,157
U54 · FY2018 · CA
PDX Trial Center for Breast Cancer Therapy$175,435
U54 · FY2018 · CA
Pilot Project and Trans-Network Activities Core$29,359
U54 · FY2018 · CA · contact PI
Pilot Project and Trans-Network Activities Core$29,239
U54 · FY2018 · CA · contact PI
PDX Trial Center for Breast Cancer Therapy$2,482,191
U54 · FY2017 · CA
Pilot Project and Trans-Network Activities Core$181,092
U54 · FY2017 · CA · contact PI
Analysis of the Cellular Origins of Breast Cancer$290,903
R01 · FY2014 · CA · contact PI
Analysis of the Cellular Origins of Breast Cancer$282,221
R01 · FY2013 · CA · contact PI
Analysis of the Cellular Origins of Breast Cancer$300,907
R01 · FY2012 · CA · contact PI
Analysis of the Cellular Origins of Breast Cancer$301,577
R01 · FY2011 · CA · contact PI
Analysis of the Cellular Origins of Breast Cancer$312,288
R01 · FY2010 · CA · contact PI